Immunovant, Inc. — Director's Dealing 2019

May 15, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Health Sciences Acquisitions Corp (HSACU)
CIK: 0001764013
Period of Report: 2019-05-14

Reporting Person: Health Sciences Holdings, LLC (10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-05-14	Warrants to purchase Common Stock	$11.50	P	10000000	Acquired		Common Stock (5000000)	Direct

Footnotes

F1: The warrants become exercisable on the later of (i) 30 days from the completion of the registrant's initial business combination and (ii) 12 months from the closing of the registrant's initial public offering.

F2: The warrants expire 5 years after the completion of the registrant's initial business combination or earlier upon redemption or liquidation, as described in the registrant's prospectus filed with the SEC.